Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126251411 | 12625141 | 1 | I | 20150516 | 20150701 | 20160805 | 20160805 | EXP | US-BAYER-2015-375592 | BAYER | 69.00 | YR | E | M | Y | 0.00000 | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126251411 | 12625141 | 1 | I | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | 6400 | MG | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | ||
| 126251411 | 12625141 | 2 | I | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | 6400 | MG | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | ||
| 126251411 | 12625141 | 3 | I | XARELTO | RIVAROXABAN | 1 | 6400 | MG | N | 0 | FILM-COATED TABLET | ||||||||
| 126251411 | 12625141 | 4 | PS | ACETYLSALICYLIC ACID (} 100 mg) | ASPIRIN | 1 | Oral | 325 MG, UNK | 999999 | 325 | MG | ||||||||
| 126251411 | 12625141 | 5 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 6 MG, UNK | 0 | 6 | MG | ||||||||
| 126251411 | 12625141 | 6 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126251411 | 12625141 | 7 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126251411 | 12625141 | 8 | C | OXYCODONE | OXYCODONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126251411 | 12625141 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126251411 | 12625141 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126251411 | 12625141 | 1 | Atrial fibrillation |
| 126251411 | 12625141 | 2 | Thrombosis prophylaxis |
| 126251411 | 12625141 | 3 | Cerebrovascular accident prophylaxis |
| 126251411 | 12625141 | 4 | Cardiac disorder |
| 126251411 | 12625141 | 5 | Atrial fibrillation |
| 126251411 | 12625141 | 6 | Stent placement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126251411 | 12625141 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126251411 | 12625141 | Haemorrhoidal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126251411 | 12625141 | 1 | 20140701 | 20150516 | 0 | |
| 126251411 | 12625141 | 2 | 2015 | 20150721 | 0 | |
| 126251411 | 12625141 | 4 | 201505 | 0 | ||
| 126251411 | 12625141 | 5 | 2015 | 0 | ||
| 126251411 | 12625141 | 7 | 201605 | 0 | ||
| 126251411 | 12625141 | 8 | 2011 | 0 |